MGMT and central nervous system cancer: CONCLUSION: This study revealed the cross-talk relationship between PARP and MGMT in the repair process of O6-MeG, elucidated the molecular mechanism of PARP inhibitor reversing MGMT-positive glioma drug resistance, and provided novel therapeutic strategies for clinical treatment of chemo-resistant glioma.